Menu

CME Corner

Active Programs

The Value of Biosimilars in the Treatment of Inflammatory Bowel Disease

A number of biosimilars have been approved in recent years, offering additional treatment options for patients with IBD. Given the novelty of biosimilars in the U.S., it’s not surprising that clinicians have questions. In this activity, faculty will define biosimilars, examine how they’re studied and regulated, and discuss their current and potential role in IBD management, including how they migh ...

  • Video Roundtable
  • ACCME

Expired Programs

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will e ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Optimizing Immunization in IBD: A Quality Improvement Curriculum, Part 1

This activity simulates a quality improvement initiative to illuminate best practices in the immunization of patients with IBD. ...

  • Mobile + Online on RealCME
  • ACCME
Main Menu
EDITOR'S PICKS